Table 2.
Baseline Characteristics
| Characteristic | Audit (%) | IBD Database (%) | P value |
|---|---|---|---|
| Sex (Female) | 50 | 41 | 0.12 |
| Diagnosis | |||
| Crohn's disease | 74 | 70 | 0.4 |
| Ulcerative colitis | 23 | 19 | 0.4 |
| Indeterminate colitis | 3 | 11 | 0.01 |
| Length time since diagnosis (range: years) | |||
| ≤ 5years | 64 | 55 | 0.12 |
| ≥6 years | 36 | 45 | 0.12 |
| Medication exposure (ever)* | |||
| Oral steroids (> 3 months duration) | 77 | ||
| Antiinflammatory (sulphasalazine/osalazine/mesalazine) | 88 | ||
| Immunosuppressive (azothioprine or methotrexate) | 59 | ||
| Biologic therapy (Anti TNF Infliximab) | 20 |
* some patients had multiple medications so percentages may exceed 100%